This post was written by Jay Yan, Mao Rong, Zack Dong, Zhao Hong, Gordon Schatz, Dr. David Kan and Katherine Yang.

Reed Smith’s Life Sciences Health Industry China Briefing provides a summary of the monthly news and legal developments relating to China's Pharmaceutical, Medical Device, and Life Sciences/ Health Care Industries.

Some important developments during October include:

SFDA Issues 2010 Annual Report on Drug Registration and Approval
CCTV to Restrict Advertisement of Alcohol, Medical Institutions
MOH Requires Improvement of the Reward and Penalty System for Antibacterial Drug Administration
Draft Mental Health Law Submitted to NPC Standing Committee for First Deliberation
SFDA: All Drugs on Market to Have E-ID by End of 2015
SFDA Releases 3rd Batch of Illegal Drugs, Medical Devices and Health Food Advertisements in 2011
SFDA issues Notice on Release and Delivery of GMP Certification Announcement
SFDA issues Notice concerning Circulation of the Administrative Measures on Drug Supervision in Medical Institutions
Detailed Summary of SFDA 2010 Annual Report on Drug Registration and Approval
To read the full briefing by Reed Smith China team members, click here.